论文部分内容阅读
目的研究分析雷贝拉唑三联疗法治疗消化性溃疡的作用效果。方法选择2014年9月~2015年9月在我院进行治疗的110例消化性溃疡患者,运用随机数字表法进行平均分组,对照组55例患者应用奥美拉唑、克拉霉素、阿莫西林三联疗法治疗;试验组55例患者应用雷贝拉唑、克拉霉素、阿莫西林三联疗法治疗。结果试验组患者的总有效率为92.73%(51/55)高于对照组的76.36%(42/55),差异具有统计学意义(P<0.05)。试验组患者幽门螺杆菌清除率94.55%(52/55)高于对照组的81.82%(45/55),差异具有统计学意义(P<0.05)。结论雷贝拉唑三联疗法治疗消化性溃疡的效果突出,可有效消除幽门螺杆菌,促进溃疡的愈合。
Objective To study the effect of rabeprazole triple therapy on peptic ulcer. Methods A total of 110 patients with peptic ulcer treated in our hospital from September 2014 to September 2015 were randomly divided into groups according to random number table. In the control group, 55 patients were treated with omeprazole, clarithromycin, Xilin triple therapy; experimental group of 55 patients treated with rabeprazole, clarithromycin, amoxicillin triple therapy. Results The total effective rate in the experimental group was 92.73% (51/55), which was significantly higher than that in the control group (76.36%, 42/55). The difference was statistically significant (P <0.05). The clearance rate of Helicobacter pylori in the experimental group was 94.55% (52/55), which was higher than that in the control group (81.82%, 45/55), the difference was statistically significant (P <0.05). Conclusion Rabeprazole triple therapy for the treatment of peptic ulcer prominent effect, can effectively eliminate Helicobacter pylori, promote ulcer healing.